Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
20.9M
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
13.2M
-
Shares change
-
+12.6M
-
Total reported value, excl. options
-
$186M
-
Value change
-
+$178M
-
Number of buys
-
54
-
Price
-
$14.14
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) as of Q1 2024
56 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share as of Q1 2024.
Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.2M shares
of 20.9M outstanding shares and own 62.98% of the company stock.
Largest 10 shareholders include VR Adviser, LLC (1.56M shares), Vivo Capital, LLC (1.5M shares), Logos Global Management LP (1.5M shares), VANGUARD GROUP INC (907K shares), FMR LLC (901K shares), BML Capital Management, LLC (833K shares), FRANKLIN RESOURCES INC (676K shares), COMMODORE CAPITAL LP (657K shares), MORGAN STANLEY (562K shares), and 5AM Venture Management, LLC (542K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.